November 10, 2016
Bristol-Myers to develop Nitto's investigational anti-fibrosis drug
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
November 10, 2016
Comprehensive loss for Probiodrug in the third quarter of 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
November 10, 2016
Catalyst Pharmaceuticals finishes Q3 2016 with net loss
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating …
November 10, 2016
GENFIT in deal to enhance Medical Knowledge & Landscape of NASH research
GENFIT has signed an agreement for a NASH Registry Project
November 10, 2016
Stada reports 50% net income decrease in Q3 2016 compared to same period last year
Stada reports financial results for Q3 2016…
November 9, 2016
Horizon enters into equipment manufacturing deal with CareDx
Horizon Discovery Group has entered into an Original Equipment Manufacturer (OEM) agreement with CareDx…
November 9, 2016
Bristol-Myers, Infinity Pharmaceuticals join forces to test drug in advanced solid tumors
ristol-Myers Squibb Company and Infinity Pharmaceuticals have announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo …
November 9, 2016
Change to Astrazeneca board of directors
AstraZeneca has announced that Jean-Philippe Courtois, a Non-Executive Director, will step down from the Board of AstraZeneca…
November 9, 2016
Viking Therapeutics' Chairman joins Dechra Pharmaceuticals' board
Dechra has appointed Lawson Macartney to the Board
November 9, 2016
Valneva reports financial results for first nine months of 2016
Valneva has reported financial results for first nine months of 2016.